GLP1R and diabetes mellitus: Furthermore, Medicaid expansion has influenced the uptake of newer diabetes medications; increases in rates of use of noninsulin diabetes medications, including glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter-2 inhibitors, were significantly greater in expansion states than in nonexpansion states (36).